Warning! OUTDATED BROWSER DETECTED!   Please update your browser immediately for a better experience on this website. Learn More
21/xsl/MobileMenu.xsltmobileNave880e1541/WorkArea//http://www.rsna.org/TwoColumnWireframe.aspx?pageid=15203&ekfxmen_noscript=1&ekfxmensel=falsefalsetruetruetruefalsefalse102e880e1541_21_1008.0.0.0730truefalse
  • About RSNA
  • 2014 Report of the Secretary-Treasurer

  •  

    I am pleased to report that RSNA membership continues to reach new record levels. In 2014, the Society accepted 6,414 new members.

    We annually promote membership in our Society to new radiology residents and medical students. Through this year's promotional efforts 4,479 radiology residents and medical students joined the RSNA (1,376 new Members-in-training, 1,504 new Corresponding Members-in-training, 128 Fellows, and 554 Medical Students).

    We are pleased to see our specialty’s future leaders taking advantage of the great opportunities offered to them through RSNA membership. Members-in-training and medical students do not pay dues, have free access to RSNA benefits like Online Education and myRSNA, are allowed free admission to the RSNA Scientific Assembly and Annual Meeting, and receive access to the journals Radiology and RadioGraphics or subscribe to the printed versions of the journals at a highly subsidized rate.

     

     

     

    RSNA RECORD OF MEMBERSHIP

     

    Active

    Assoc

    Med Stu

    MIT

    Cor.-MIT

    Retired

    Honorary

    Corresp

    Totals

    2014

    19,751

    1,848

    1,783

    10,508

    8,352

    5,141

    66

    6,841

    54,290

    2013

    20,133

    1,860

    1,779

    10,343

    7,584

    4,941

    66

    6,325

    53,031

       

    Net Increase

    1,259

    I regret to report the passing of the colleagues named below as of October 31, 2014. RSNA mourns their deaths while honoring their service to the health and well-being of the communities in which they practiced medicine.

    DECEASED RSNA MEMBERS FROM 11/1/13 - 10/31/14

    Ralph H. Baehr, MD, Greenville, SC (R66) 
    William E. Beamish, MD, Edmonton, AB Canada (R82)  
    John L. Bircher, MD, Saint Louis, MO (R58) 
    Ralph H. Brancaccio, MD, Saint Petersburg, FL (R49) 
    Yvan Brassard, MD, Valleyfield, QC Canada (R60) 
    Byron G. Brogdon, MD, Mobile, AL (R58) 
    Anne C. Brower, MD, Tubac, AZ (R72) 
    James C. Carlson, MS, Greenwood, IN (R60) 
    James H. Chapman, MD, Overland Park, KS (R65) 
    Chusilp Charnsangavej, MD, Houston, TX (M83) 
    William A. Chervenak, MD, Saint Paul, MN (R66) 
    Douglas W. Cockburn, MD, Nepean, ON Canada (R55) 
    William C. Constable, MD, Troy, VA (R75) 
    Emmett M. Cooper, MD, Winter Park, FL (R65) 
    John H. Deaton Jr, MD, Columbus, GA (R62) 
    James E. Durlacher, BS, Indianapolis, IN (R53) 
    Mina K. Edelman, MD, Saint Louis, MO (R55) 
    Michael J. Estner, MD, Jacksonville, FL (M04) 
    Leland R. Felton, MD, San Francisco, CA (R51) 
    Geoffrey A. Fricker, MD, Mill Valley, CA (R51) 
    John W. Fries, MD, Saint Louis, MO (R53) 
    Benjamin M. Galkin, MS, Cherry Hill, NJ (R65) 
    Manohar P. Gandhi, MD, Encino, CA (R76) 
    Frank W. Gearing Jr, MD, Harrisonburg, VA (R61) 
    Stuart W. Gibbs, MD, Gastonia, NC (R48) 
    Louis A. Gilula, MD, Saint Louis, MO (R74) 
    Joseph N. Gitlin, DPH, Silver Spring, MD (R73) 
    Ronald G. Grainger, MD, Sheffield, United Kingdom (H81) 
    Paul H. Guttman Jr, MD, Incline Village, NV (R83) 
    William S. Hare, MD, Brighton, VIC Australia (H84) 
    David L. Herbert, MD, Port Macquarie, NSW Australia (R80) 
    Christopher C. Higgins, MD, Battle Creek, MI (R72) 
    R. Brian Holmes, MD, Toronto, ON Canada (RP56) 
    Thomas J. Kennedy, MD, Greenwood Village, CO (R48) 
    Seuk K. Kim, MD, Fayetteville, NY (R65) 
    Donald P. King, MD, Richmond, VA (R57) 
    Thomas E. Kirk, MD, Jacksonville, FL (R68) 
    Charles M. Klein, MD, Jupiter, FL (R66) 
    Omar Legant, MD, Albuquerque, NM (R55) 
    Lucien M. Levy, MD, PhD, Columbia, MD (M84) 
    Michael Lewiski, MD, Vancouver, WA (R66) 
    Clarence J. Ludwig, MD, Sarasota, FL (R65) 
    Kevin L. Macken, MD, North White Plains, NY (R65) 
    William B. McAvoy, MD, McKeesport, PA (R73) 
    Vernon L. Medlin, MD, Corpus Christi, TX (R67) 
    James C. Neering, MD, Rochester, MI (R62) 
    Harvey L. Neiman, MD, Mc Lean, VA (R77) 
    Mario Nunez, MD, Oak Brook, IL (R68) 
    Javier Antonio Opazo Verdugo, MD, San Pedro de la Paz, Chile (F203) 
    S
    ven J. Paulin, MD, PhD, Needham, MA (R77) 
    Catherine A. Poole, MD, West Chester, PA (R66) 
    Paul W. Scanlon, MD, Marco Island, FL (R53) 
    Juan M. Sanchez, MD, Mexico City, DF Mexico (M90) 
    Carl W. Scheer, MD, Aiea, HI (R68) 
    Leslie Schlesinger, MD, La Jolla, CA (R65) 
    Martin M. Shaperman, MD, Sherman Oaks, CA (R85) 
    Michael S. Sidell, MD, Mundelein, IL (R72) 
    Robert T. Smith, MD, Huntsville, AL (R80) 
    Claire H. Smith, MD, Chicago, IL (R77) 
    Lloyd Spindell, MD, Boca Raton, FL (R66) 
    Michael J. Stamatakos, MD, Allentown, PA (R75) 
    Harold K. Standing, MD, Winnipeg, MB Canada (R70) 
    Thomas T. Thompson, MD, Wilmington, NC (R73)  
    William J. Tuddenham, MD, Naples, FL (R60) 
    Donald M. Wald, MD, Morgantown, WV (R59) 
    Charles R. Walker, MD, Beaumont, TX (R57) 
    Warren A. Wass, MD, Woodbridge, CA (R55) 
    Alfred L. Weber, MD, Milton, MA (R69) 
    Lawrence H. Welter, MD, Walnut Creek, CA (R73) 
    Bart M. Wiarda, MD, Alkmaar, Netherlands (R04) 
    Hugh A. Wiegman, MD, Lawrence, KS (R73) 
    Robert G. Williams, MD, Santa Barbara, CA (R50) 

    FINANCIAL STATEMENTS

    The financial statements for the fiscal year ended June 30, 2014, reflect positive earnings for the Society.

    The Society continues to experience financial growth. This is a result of maintaining its revenue sources and at the same time controlling its expenses.  The return on investments is especially important for the Society’s Research and Education Foundation, as its ability to fund grants is directly impacted by investment earnings.

    Wolf & Company LLP completed its annual audit of the Society's financial statements issuing an unmodified opinion, indicating that Wolf & Company LLP found no material differences to the financial information presented in the Society's year-end financial statements. In addition Wolf & Company LLP indicated to the Audit Committee that it did not find any material weaknesses in the Society's internal accounting procedures.

    The following Balance Sheet and Statement of Activities have been condensed from the year-end audit report prepared by Wolf & Company LLP, as of June 30, 2014. The detailed audited report is kept on file at the RSNA's headquarters: Radiological Society of North America, 820 Jorie Boulevard, Oak Brook, IL 60523. It is available for review there by members of the RSNA.

    Ronald L. Arenson, MD 
    Secretary-Treasurer 

    Statement of Financial Position
    June 30, 2014

    ASSETS

     

    Cash and Short-Term Investments

    $4,245,098

    Receivables and Other Current Assets

    5,074,664

    Long-Term Investments  

      115,736,018

    Property, Furniture and Equipment

    22,302,061

    Total Assets

    $147,357,841

     

    Liabilities and Net Assets

     

    Accounts Payable and Short-Term Debt

    $3,651,869

    Deferred Revenue

    13,314,181

    Long-Term Debt and Other Long-Term Liabilities

    2,405,254

    Net Assets:

     

      Unrestricted:

     

         Undesignated

    56,948,884

    Designated-Research and Education Foundation

    44,302,662

      Restricted:

     

        Temporarily restricted

    4,060,015

        Permanently restricted

    22,674,976

    Total net assets

    127,986,537

    Total Liabilities and Net Assets

    $147,357,841

     

    Statement of Activities
    Year ending June 30, 2014

    REVENUE

     

    Membership Services

    $6,127,745

    Publications and Educational Materials

    13,286,118

    Annual Scientific Assembly

    23,143,138

    Investment Earnings

    8,753,380

    Contributions

    2,862,880

    Total Revenue

    $54,173,261

     

    EXPENSES

     

    Membership Services

    $6,679,477

    Publications and Educational Materials

    17,175,979

    Annual Scientific Assembly

    14,396,977

    Research and Education Foundation

    4,811,430

    Depreciation

    1,198,066

    Total Expenses

    $44,261,929



    Excess of operating revenue over operating expenses

    $9,911,331

    Federal and state income tax expense           

    (127,792)

    Non operating income

    $114,854

    Increase in net assets before unrealized gain (loss) on investments

    $9,898,393

    Unrealized gain (loss) on valuation of investments and interest rate swap

    $4,734,055

     

    Increase in Net Assets

    $14,632,448

    Net Assets at beginning of year

    $113,354,089

    Net Assets at end of year

    $127,986,537

    2014 Total Revenue pie chart

    2014 Total Expense pie chart

     

    Ronald L. Arenson, MD Secretary-Treasurer